Marshall Wace, LLP Ovid Therapeutics Inc. Transaction History
Marshall Wace, LLP
- $90.8 Billion
- Q3 2025
A detailed history of Marshall Wace, LLP transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 783,653 shares of OVID stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
783,653
Previous 164,721
375.75%
Holding current value
$1.03 Million
Previous $54,000
1757.41%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding OVID
# of Institutions
87Shares Held
33.1MCall Options Held
141KPut Options Held
62.5K-
Black Rock Inc. New York, NY3.99MShares$5.23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$3.7 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.65MShares$3.47 Million0.39% of portfolio
-
Acadian Asset Management LLC Boston, MA2.29MShares$3 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.02MShares$2.64 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $92.2M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...